Global Considerations in Kidney Disease: Latin America

Key Points

  • The lack of national and regional registries limits understanding the true burden of kidney diseases in Latin America (LA).

  • LA is one of the regions with the highest prevalence and incidence of kidney diseases, which, can be explained partly by the large number of patients with diabetes, obesity, and hypertension.

  • The Mesoamerican region suffers from a particular entity, Mesoamerican nephropathy, which is of unknown etiology, but agrochemicals and high temperatures are the most studied attributable factors.

  • The sociocultural and economic conditions of many regions of LA have limited comprehensive care for kidney pathologies; most people have incomplete access to kidney replacement therapies such as dialysis or transplant.

  • Acute kidney injury in the Latin American region is predominantly acquired in the community. It has etiologies such as dehydration, heat stroke, insect bites, snakes, and poisoning.

  • The epidemiology of subgroups such as pediatrics, geriatrics, and pregnancy is underrepresented in the region.

Latin America (LA) is a geographic region that includes Mexico and the Caribbean Islands in the north to the southern cone shared by Argentina and Chile and covers an area of 20.425 million km. It includes 20 countries with a growing population of 654 million people and a life expectancy of 72 years. Latin Americans form a diverse ethnic and cultural group of Romance language (Spanish, Portuguese, and French)–speaking people of predominantly European ancestry mixed with indigenous and African roots.

LA has proved relatively resilient in the face of rising debt stress, inflation, and the COVID-19 pandemic. Income and employment have largely recovered. Current GDP is $US 5.45 trillion and a gross domestic product (GDP) per capita of $US 8327, close to 2019 levels. However, government health care spending in 2019 was estimated at 7.9% of GDP across the region, compared with the Organization for Economic Cooperation and Development health care expenditure of 9.6%. Irrespective of estimate, expenditure varies widely across each country, with Cuba spending 12.4% of its GDP on health care, while Haiti spent just 3.3% 3-5. ( Table 74.1 ). Data on quality of care and health care inequalities remain unavailable for many countries in LA.

Table 74.1

Sociodemographic, Health Expenditure, Nephrologist Manpower, Prevalence, and Access to Kidney Replacement Therapy in Latin America and the Latin Caribbean

Country Population a GDP Per Capita (US$) LEB (years) Expenditure on Health Per Capita (US$) Expenditure on Health (% of GDP) Nephrologists(pmp) Access to KRT (%) b Prevalence of Treated ESKD (pmp) b
Central America, Mexico, and Latin Caribbean
Costa Rica 5 , 123 , 105 12,670 81 953.08 7.86 5 100 567
Cuba 11 , 300 , 698 9126 78 1186.16 12.49 44 100 430
Dominican Republic 10 , 999 , 664 8282 73 354.10 4.94 16 67 485
Guatemala 17 , 362 , 718 4363 72 289.13 6.47 5 100 575
Haiti 11 , 306 , 801 1205 64 45.42 3.31 0.6 N/A N/A
Honduras 10 , 121 , 763 2575 72 212.70 9.04 3 25 405
El Salvador 6,292,731 4187 75 385.74 9.85 9 40 776
Mexico 125,998,302 9946 76 538.57 6.24 9 51 1823
Nicaragua 6,755,895 1913 75 161.20 8.63 5 50 111
Panama 4,294,396 15,728 79 1214.75 9.66 9 80 701
Puerto Rico 3,193,694 32,916 79 N/A N/A 23 92 2129
Andean Region
Bolivia 11,936,162 3552 72 241.12 7.86 7 90 457
Colombia 50,930,662 6425 79 477.27 8.99 8 100 858
Ecuador 17,588,595 6223 78 478.53 8.48 12 100 768
Peru 33,304,756 7097 80 388.55 6.3 11 100 618
Venezuela 28,490,453 6613 74 142.46 3.82 18 100 320
Southern Cone and Brazil
Argentina 45,036,032 9947 77 863.71 9.98 25 100 963
Brazil 213,196,304 8898 76 700.71 10.31 20 100 963
Chile 19,300,315 14,742 81 1278.18 9.75 7 100 1550
Paraguay 6,618,695 5415 76 405.63 7.58 9 100 387
Uruguay 3,429,086 17,768 77 1429.51 9.15 51 100 1194

ESKD, End-stage kidney disease; GDP, gross domestic product; KRT, kidney replacement therapy; LEB, life expectancy at birth; US$, U.S. dollars.

In recent decades, the region has experienced a demographic and epidemiologic transition, with reductions win child mortality and communicable diseases, longer life expectancy, and rapid urbanization triggering a surge in lifestyle-associated noncommunicable diseases (NCD). Currently, the region has the largest migration crisis in history. In addition to the traditional flows from Central America and Mexico to the United States, Venezuela, and Haiti have been the source of large outflows. This situation is exacerbated by the effects of climate change, which has caused significant economic and social losses. Hurricanes, floods, and droughts are becoming more frequent, and it is estimated that 17 million people could be forced to leave their homes and nearly 5.8 million people could fall into extreme poverty by 2030, mainly due to a lack of safe drinking water, as well as increased exposure to excessive heat and flooding, increasing the risk of acute kidney injury (AKI) and chronic kidney disease (CKD). Additionally, forced migration and climate change represent a serious challenge to host countries to provide renal health care including dialysis and kidney transplantation to an increasingly growing migrant population. ,

Chronic Kidney Disease in Latin America

Kidney disease has become a public health problem in LA. The prevalence of CKD has been estimated at 10.1%, with Haiti reporting the highest (14.0%) and Bolivia the lowest prevalence (6.3%). , According to the Global Burden of Disease study (1990–2019), the LA and Caribbean region was estimated to have the greatest burden of CKD among all world regions. Age-standardized disability-adjusted life years (DALYs) rates were highest in Central and Andean LA, at 1348.1 and 836.3 per 100,000 population, respectively, compared with the global rate of 514.9 per 100,000 population. CKD was also the leading cause of mortality and disease burden in the region in 2019 ( Table 74.2 ). Kidney disease represented the 8th cause of mortality and the 10th cause of years of life lost (YYLs) and DALYs in both sexes combined, and it was among the causes with the highest increase in the region ( Figs. 74.1 to 74.3 ).

Table 74.2

Mortality, DALYs, and YYLs Attributable to CKD in Latin America and Latin Caribbean

Reproduced from: Pan American Health Organization. The burden of kidney diseases in the Region of the Americas, 2000-2019. Washington, D.C.: PAHO; 2021. Available from: https://www.paho.org/en/enlace/burden-kidney-diseases and accessed on 11th May 2025.

Country Deaths Per 100,000 Population(95% UI) DALYsPer 100,000 Population(95% UI) YLL Per 100,000 Population (95% UI)
Central America, Mexico and the Latin Caribbean
Costa Rica 23.4 (12.4-39.1) 737 (316-1159) 525 (267-899)
Cuba 8.3 (4.5-13.6) 344 (161-527) 209 (108-348)
Dominican Republic 20.8 (9.8-37.9) 671 (211-1130) 523 (238-975)
Guatemala 55.1 (29.9-90.6) 1625 (645-2605) 1403 (733-2361)
Haiti 35.0 (15.4-70.4) 1166 (390-1943) 1000 (425-2026)
Honduras 49.4 (24.6-88.3) 1299 (388-2210) 1115 (534-2029)
El Salvador 72.9 (37.4-124.3) 2122 (693-3551) 1877 (925-3288)
Mexico 36.7 (21.4-55.9) 1210 (656-1763) 911 (514-1415)
Nicaragua 73.9 (40.2-120.2) 2036 (836-3236) 1785 (939-2959)
Panama 23.9 (12.8-39.6) 710 (303-1117) 519 (267-881)
Andean Region
Bolivia
Colombia 12.3 (6.5-20.5) 398 (174-621) 251 (129-430)
Ecuador 37.4 (20.4-60.7) 935 (391-1479) 794 (417-1321)
Peru 21.3 (10.7-36.9) 572 (201-943) 464 (225-824)
Venezuela 21.8 (11.5-36.2) 671 (286-1056) 475 (241-811)
Southern Cone and Brazil
Argentina 21.5 (12.3-33.6) 530 (256-805) 438 (241-700)
Brazil 15.5 (9.3-22.5) 449 (267-631) 336 (199-496)
Chile 13.5 (7.8-21.0) 324 (163-484) 239 (134-379)
Paraguay 27.9 (14.6-46.8) 781 (299-1263) 648 (327-1115)
Uruguay 14.1 (8.8-21.0) 338 (186-490) 270 (166-407)

CKD, Chronic kidney disease; DALY, disability-adjusted life years; UI, uncertainty interval; YYL, years of life lost.

Fig. 74.1

Age-standardized death rates due to CKD in Latin America and the Latin Caribbean, per 100,000 population in 2019.

Reproduced from: Pan American Health Organization. The burden of kidney diseases in the Region of the Americas, 2000-2019. Washington, D.C.: PAHO; 2021. Available from: https://www.paho.org/en/enlace/burden-kidney-diseases ; and accessed on 11th May 2025.

Fig. 74.2

Age-standardized disability-adjusted life years (DALYs) due to chronic kidney disease in Latin America and the Latin Caribbean, per 100,000 population in 2019.

Reproduced from: Pan American Health Organization. The burden of kidney diseases in the Region of the Americas, 2000-2019. Washington, D.C.: PAHO; 2021. Available from: https://www.paho.org/en/enlace/burden-kidney-diseases and accessed on 11th May 2025.

Fig. 74.3

Age-standardized years of life lost (YLLs) due to chronic kidney disease in Latin America and the Latin Caribbean, per 100,000 population in 2019.

Reproduced from: Pan American Health Organization. The burden of kidney diseases in the Region of the Americas, 2000-2019. Washington, D.C.: PAHO; 2021. Available from: https://www.paho.org/en/enlace/burden-kidney-diseases and accessed on 11th May 2025.

Risk Factors for Chronic Kidney Disease

The three leading causes of mortality and DALYs in LA, particularly in Central America and the Caribbean, were diabetes, arterial hypertension, and obesity, with an annual increase rate change in all-age DALYs from 2010 to 2019 between 1.6% and 5.0%.

Chronic Kidney Disease Related to Diabetes in Latin America

Diabetes is by far the leading cause (36%) of treated end-stage kidney disease (ESKD), representing 67%, 58%, and 48% of incident dialysis patients in Puerto Rico, Mexico, and Paraguay, respectively, followed by hypertension and chronic glomerular disease. On average, the prevalence of diabetes in LA countries was 9.7%. Mexico was the country that experienced the largest increase in diabetes prevalence, of 4.40 percentage points, while the prevalence in Venezuela and Uruguay decreased around 6 percentage points in the 2010–2019 period. The burden of diabetes and kidney diseases is particularly high compared with the global average, equivalent to 2560 DALYs per 100,000 population compared with a global average of 1460 DALYs per 100,000 population.

Chronic Kidney Disease Related to Hypertension in Latin America

Hypertension is the most important risk factor contributing to the burden of cardiovascular disease and the leading cause of death in all LA countries. Close to 22% of the adult LA population is estimated to be affected by hypertension, below the global average of 30%. Peru and Panama have the highest prevalence of 25%, while the lowest prevalence was observed in the Dominican Republic (17.9%) and Paraguay, the only country below 15%. Between 2005 and 2015, most LA countries reduced the prevalence of raised blood pressure with an average of-8%. Changes in risk factors and improvements in detection and treatment of raised blood pressure have, at least partly, contributed to these general reductions. ,

Chronic Kidney Disease Related to Obesity in Latin America

Overweight and obesity are major public health concerns in the region. Obesity is an established risk factor for hypertension, diabetes, and cardiovascular disease. In LA countries, 63% of women and 53% of men are overweight (overweight + obesity). Between 2010 and 2016, the overweight population increased 6% in women and 9% in men. In LA countries, obesity is higher among women (29%) than men (18%). Social determinants of health such as poverty, inadequate water and sanitation, and inequitable access to education and health services underlie the epidemic of obesity and diabetes in the region. A key driver is a changing food environment, in which nutrient-poor and energy-dense processed foods are being aggressively marketed.

Mesoamerican Nephropathy—Chronic Kidney Disease of Unknown Cause

An endemic type of CKD of unknown origin (also known as “Mesoamerican Nephropathy” [MeN]) has been described in the region, particularly in El Salvador, Guatemala, Honduras, Nicaragua, Mexico, and Paraguay. , This form of CKD has been most consistently reported among agricultural workers, , has a higher prevalence in men, favors regions at lower altitudes, and particularly affects workers in sugar cane plantations. This form of CKD of unknown cause, named MeN, is endemic to Pacific coastal communities in Central America. 20.

The clinical presentation of MeN is characterized by an elevation of serum creatinine level and non-nephrotic proteinuria, predominantly in young men without evidence of any known risk factors for CKD such as hypertension or diabetes, raising the possibility of a tubulointerstitial kidney disease due to an unknown environmental or occupational hazard. Various hypotheses have been described including ischemic injury as a result of the heavy physical work in a hot climate leading to repeated episodes of chronic dehydration with AKI after working hours. The temperature in Mesoamerica has increased significantly, and recent evidence has shown that kidney tubules can be damaged by heat stress. Nonetheless, it is likely that multiple “hits” are necessary. In kidney biopsies from eight male sugarcane workers (aged 22−57 years) from a rural area of El Salvador who had presented with impaired kidney function (estimated glomerular filtration rate (GFR) between 27 and 77 mL/min/1.73 m 2 ), inactive urinary sediment, and non-nephrotic proteinuria, , the morphologic picture was similar in all patients, showing chronic tubulointerstitial injury with tubular atrophy and interstitial fibrosis, and a surprising finding was the presence of relatively extensive glomerular sclerosis. These findings suggest primary tubulointerstitial disease.

Other authors have also described acute interstitial nephritis in young people without other comorbidities who had abnormalities in kidney function markers.

Kidney tubular injury may also be induced by pesticides used in agriculture, which induce proximal tubular injury similar to that observed with calcineurin inhibitors. The pesticide paraquat has been shown to be strongly associated with the progression of CKD in exposed individuals in regions of Central America. Acute heavy metal exposure has also been implicated in Central American communities, especially in a town in Mexico called Poncitlan, where its inhabitants have one of the highest prevalence of CKD of undetermined etiology in the world. Another of the most commented hypotheses are those derived from fructose. , It is likely that there is also a genetic predisposition for MeN. In a municipality in Mexico where MeN is highly prevalent, genetic variants of ATP6V0A2 were identified in more than 30% of the affected population. ATP6V0A2 encodes the ATPase pump of the lysosomal H+ transporter in the kidney tubule. Thus it is possible that MeN may be a kidney disease due to a combination of genetic predisposition, with chronic dehydration leading to tubulointerstitial injury , and toxins (e.g., pesticides) or heavy metals contributing as second hits in the development of the disease. Although originally reported in Central America, MeN could represent a larger entity, explaining CKD epidemics seen in countries such as Sri Lanka, Bangladesh, and central Australia.

Heat stress nephropathy

Heat stress is a syndrome that can occur in hot environments during the summer months. , When heat waves persist for consecutive days, the risk of AKI and CKD increases. Dehydration, a common condition among workers in agriculture, construction, firefighters, and miners, is a significant risk factor for nephropathy. Recurrent dehydration increases serum osmolarity and activates the polyol pathway in the kidney, leading to increased conversion of glucose to sorbitol and fructose. Fructose in turn can be metabolized by the fructokinase that is constitutively present, resulting in the generation of uric acid, oxidants, and chemokines, which can cause local tubulointerstitial injury. Mice with knockout of fructokinase are protected from CKD when subjected to repeated dehydration. Heat stress and strenuous physical work can also lead to rhabdomyolysis. Continuous episodes of rhabdomyolysis are associated with elevated uric acid levels. This episode of environmentally associated AKI could be related to unknown CKD (CKDu) or MeN as discussed earlier. ,

End-Stage Kidney Disease in Latin America

ESKD continues to grow in the region. In 2019, the median prevalence of treated ESKD in the region was 866 per million population (pmp), compared with 335 pmp in 2000 ( Fig. 74.4 ), and the median number of incident cases was 168 pmp. Mexico and Puerto Rico have the highest rates of ESKD in the region. In most countries more than 90% of the dialysis patients receive hemodialysis, except for Costa Rica (83.9%) (see Fig. 74.5 ), Nicaragua (65%), El Salvador (56.1%), where peritoneal dialysis (PD) accounted for more than half of dialysis treatment. Patients living with a functioning kidney graft represented >20% of all treated ESKD patients, but variability is high between countries ( Table 74.3 ). The mean number of nephrologists in the region is 19 pmp but varies widely across LA, from 3.3 pmp in Honduras to 51 pmp in Uruguay. Only Argentina, Cuba, Puerto Rico, and Uruguay have >20 nephrologist pmp (see Table 74.1 ).

Fig. 74.4

Prevalence of treated end-stage kidney disease and kidney transplantation rates in Latin America and the Latin Caribbean, 2000–2021.

Fig. 74.5

Prevalence of treated end-stage kidney disease by treatment modality in Latin America and the Latin Caribbean, 2019.

From SLANH. Registro Latinoamericano de Diálisis y Trasplante. Reporte 2021.

Registros
; 2023. Accessed March 2023.

Table 74.3

Incidence and Prevalence of Treated End-Stage Kidney Disease by Treatment Modality in Latin America and Latin Caribbean, 2019

Modified from Luxardo R, Ceretta L, González-Bedat M, et al. The Latin American Dialysis and Renal Transplantation Registry: report 2019. Clin Kidney J . 2022;15(3):425–431.

Prevalence Rate (pmp)
Country Population Incidence Rate (pmp) HD PD Total Dialysis % on PD FKG Total Prevalence (pmp) Kidney Transplant Rate (pmp)
Central America, Mexico, and Latin Caribbean
Costa Rica 5,123,105 38 40 209 249 83.9 318 567 15
Cuba 11,300,698 108 293 6 299 2.0 131 430 15
Dominican Republic 10,999,664 221 340 98 438 22.3 47 485 5
Guatemala 17,362,718 140 304 221 525 42.0 51 575 6
Haiti 11,306,801 N/A N/A N/A N/A N/A N/A N/A N/A
Honduras 10,121,763 96 370 22 392 5.6 13 405 0
El Salvador 6,292,731 217 297 380 677 56.1 99 776 6
Mexico 125,998,302 530 611 483 1094 44.1 729 1823 62
Nicaragua 6,755,895 31 35 65 100 65.0 11 111 2
Panama 4,294,396 181 488 113 601 18.8 100 701 8
Puerto Rico 3,193,694 419 1607 130 1737 7.4 392 2129 18
Andean Region
Bolivia 11,936,162 114 452 2 454 0.44 3 457 2
Colombia 50,930,662 103 516 185 701 26.3 157 858 19
Ecuador 17,588,595 6 735 21 756 2.7 12 768 13
Peru 33,304,756 62 515 57 572 9.9 46 618 3
Venezuela 28,490,453 96 310 10 320 3.1 0 320 1
Southern Cone and Brazil
Argentina 45,036,032 163 674 46 720 6.3 243 963 35
Brazil 213,196,304 218 618 47 665 7.0 299 963 30
Chile 19,300,315 204 1236 81 1317 6.1 233 1550 22
Paraguay 6,618,695 36 317 16 333 4.8 54 387 4
Uruguay 3,429,086 185 734 62 796 7.7 398 1194 42

FKG, Functioning kidney graft; HD, hemodialysis.

In most countries, a mixture of public and private health care systems provides funding for kidney replacement therapies (KRTs). Currently, 55% of LA countries provide KRT free at the point of delivery (see Table 74.1 ). , , In the region, the median annual costs per person for maintenance hemodialysis (HD) ($US 17,454) and maintenance PD ($US 16,825) were below global averages ($US 22,617 and $US 20,524, respectively). , , The annual cost of kidney transplantation in the first year including surgery ranged from $7458 in Brazil to $21,207 in Argentina. Except for those countries with universal access to KRT, where patients incurred no costs, out-of-pocket costs for KRT range between 1% and 25%, being higher for transplantation. The median number of HD centers was 4.55 pmp, with the highest rates reported in Chile, Argentina, and Uruguay (13.0, 13.0, and 11.0 pmp, respectively) and the lowest in Haiti and Guatemala (0.65 and 0.90 pmp, respectively). , Home HD is not practiced in the region. In two-thirds of countries, more than half of HD patients began treatment with a temporary dialysis catheter. The median number of PD centers in the region was 0.96 pmp, which was below the global average. Twelve countries (67%) were able to offer adequate frequency of exchanges, whereas just over half had the capacity to measure PD adequacy. ,

Transplantation

Kidney transplantation in LA started in Argentina in 1957, followed by Mexico (1963), Brazil (1964), Chile, and Colombia (1966). Kidney transplantation is available in 17 (94%) countries, with a regional median of 0.5 transplant centers pmp, above the global median of 0.42 pmp. Mexico and Argentina have the highest capacity for transplantation (2.16 and 1.39 transplant centers pmp, respectively , ). All countries with transplant capacity perform a combination of deceased and living-donor kidney transplants, except for El Salvador, which has capacity for living-donor kidney transplants only. The kidney transplant rate has doubled over the past 2 decades, from 11 transplants pmp in 2000 to 22 transplants pmp in 2019 ( Fig. 74.6 ). The country-specific deceased organ transplantation rate is heterogenous, with Uruguay, Brazil, and Argentina reporting the higher rates of deceased-donor kidney transplantation in the region (33.8, 20.8, and 16.0 pmp, respectively), and >70% of their transplants were from deceased donors. Most countries (63%) with kidney transplantation available had national transplant waitlists, whereas the rest had regional lists only. , ,

May 3, 2026 | Posted by in NEPHROLOGY | Comments Off on Global Considerations in Kidney Disease: Latin America

Full access? Get Clinical Tree

Get Clinical Tree app for offline access